Toronto Rehabilitation Institute, Dental Department
Toronto, Ontario, M5G 2A2, Canada
NCT Number: NCT01718912
Many physically handicapped patients at the dental department, Toronto Rehabilitation Institute(TRI) have considerable gingival inflammation and breath odour because of the inability to effectively handle a toothbrush. These patients have considerable periodontal disease. There is a concern that these pathogens may have a detrimental effect on wound healing in other areas of the body.
Hypothesis: Patients attending the dental department at TRI that are treated with the antibiotic-antifungal rinse containing metronidazole and nystatin will show substantial decrease in periodontal disease as measured by bleeding points and pocket depth when compared to the group that continues to use their regular oral hygiene methods (control group).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G 2A2, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participants must be between the ages of 18 to 65 years Participants must have at least 6 teeth. Participants must have some indication of gingivitis and periodontal breakdown. -
Exclusion criteria
Patients who are taking Warfarin/Coumadin Patients who are allergic to Metronidazole or chlorhexidine. Edentulous patients will be excluded by those who have at least 6 teeth can be a participant
-
Time frame: two weeks
Evidence of healing of periodontal tissues is assessed by measuring bleeding points and periodontal pocket depth using a dental probe.
Oravital Inc
Industry
The Effect of an Antibiotic-antifungal Rinse on Periodontal Disease
Acronym: PDT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06836401
Mouth Diseases, Periodontal Disease
Salamanca, Spain
View Trial DetailsNCT07731113
Adjunctive Periodontal Therapy, Biofilm Control
Giza, Giza Governorate, Egypt
View Trial DetailsNCT07707063
Mouth Diseases, Non Smokers
Tunis, Mont Fleury, Tunisia
View Trial DetailsNCT07446127
Mouth Diseases, Periodontal Atrophy
Afula, North, Israel
View Trial Details